HRT Financial’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.34M Buy
+92,424
New +$5.25M 0.01% 1015
2025
Q2
Sell
-5,213
Closed -$461K 3620
2025
Q1
$461K Sell
5,213
-788
-13% -$68.4K ﹤0.01% 1510
2024
Q4
$461K Buy
+6,001
New +$419K ﹤0.01% 1492
2024
Q2
Sell
-38,654
Closed -$352K 3210
2024
Q1
$352K Buy
+38,654
New +$232K ﹤0.01% 1460
2023
Q1
Sell
-17,299
Closed -$150K 3273
2022
Q4
$150K Buy
+17,299
New +$381K ﹤0.01% 1995
2022
Q2
Sell
-10,279
Closed -$1.04M 3831
2022
Q1
$1.04M Sell
10,279
-3,962
-28% -$440K 0.01% 992
2021
Q4
$2.1M Buy
+14,241
New +$3.18M 0.01% 631
2021
Q3
Sell
-773
Closed -$357K 3818
2021
Q2
$357K Buy
773
+295
+62% +$127K ﹤0.01% 2037
2021
Q1
$234K Buy
+478
New +$249K ﹤0.01% 2237

Other funds holding WGS

HRT Financial's WGS Position: Q2 2026 in Review

HRT Financial opened a new position in GeneDx Holdings (WGS) in Q2 2026: 92,424 shares worth $6.34M. The stake represents 0.01% of the portfolio and ranks #1015 among its holdings. This is a return to the name: HRT Financial previously reported a position in WGS as recently as Q1 2025.

HRT Financial first reported a position in WGS in Q1 2021 and has held it in 9 quarters since. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • HRT Financial held 92,424 shares of GeneDx Holdings worth $6.34M as of Q2 2026.
  • GeneDx Holdings was a new HRT Financial position in Q2 2026.
  • GeneDx Holdings made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1015 holding.
  • HRT Financial first reported a position in GeneDx Holdings in Q1 2021 and has held it in 9 quarters since.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.